Methadone

Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl- D -aspartate receptor antagonist. These mechanisms of action make methadone an attractive option for complex pain syndromes. It is critically...

Full description

Saved in:
Bibliographic Details
Published in:Hematology/oncology clinics of North America Vol. 32; no. 3; pp. 405 - 415
Main Authors: McPherson, Mary Lynn, PharmD, MA, MDE, BCPS, CPE, Costantino, Ryan C., PharmD, BCPS, BCGP, McPherson, Alexandra L., PharmD, MPH
Format: Journal Article
Language:English
Published: Elsevier Inc 01-06-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl- D -aspartate receptor antagonist. These mechanisms of action make methadone an attractive option for complex pain syndromes. It is critically important that providers consider a patient’s risk status before beginning methadone. Careful consideration must be given to dosing methadone in both opioid-naïve and opioid-tolerant patients, with vigilant monitoring for therapeutic effectiveness and potential toxicity until the patient achieves steady state.
AbstractList Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl-D-aspartate receptor antagonist. These mechanisms of action make methadone an attractive option for complex pain syndromes. It is critically important that providers consider a patient’s risk status before beginning methadone. Careful consideration must be given to dosing methadone in both opioid-naïve and opioid-tolerant patients, with vigilant monitoring for therapeutic effectiveness and potential toxicity until the patient achieves steady state.
Author McPherson, Alexandra L., PharmD, MPH
Costantino, Ryan C., PharmD, BCPS, BCGP
McPherson, Mary Lynn, PharmD, MA, MDE, BCPS, CPE
Author_xml – sequence: 1
  fullname: McPherson, Mary Lynn, PharmD, MA, MDE, BCPS, CPE
– sequence: 2
  fullname: Costantino, Ryan C., PharmD, BCPS, BCGP
– sequence: 3
  fullname: McPherson, Alexandra L., PharmD, MPH
BookMark eNp9kE9LxDAQR4OsYHf1A_ghWidtskkRBFn8B4oH9Tx0JxM2dW0lWYX99qasJw-e5vR-zHtzMRvGgYU4l1BJkMuLvtqMVNUgbQWyAlBHopBa21K2xsxEAda2pdXWnoh5Sj2A1GBVIYon3m06l8dOxbHvtonPfu9CvN3evK7uy8fnu4fV9WNJeUqV7GC9rNfU1opIOWMskXWqZaelbY02HbBtvSelQS0z4htDnhulXdOB9s1CyMMuxTGlyB4_Y_jo4h4l4OSCPWYXnFwQJGaXzFweGM6PfQeOmCjwQOxCZNqhG8O_9NUfmrZhCNRt33nPqR-_4pCNUWKqEfBlajWlkrbJnZRufgBjemYW
CitedBy_id crossref_primary_10_1089_jpm_2021_0561
crossref_primary_10_32388_ABG3ZQ
crossref_primary_10_3389_fphar_2020_00566
crossref_primary_10_1007_s10143_020_01415_y
crossref_primary_10_1097_NJH_0000000000000969
crossref_primary_10_3389_fimmu_2019_02914
crossref_primary_10_1016_j_brainresbull_2022_06_015
crossref_primary_10_32388_ABG3ZQ_2
crossref_primary_10_1093_oncolo_oyab081
crossref_primary_10_1007_s00520_021_06211_y
crossref_primary_10_1016_j_ijcrp_2021_200123
crossref_primary_10_4103_0973_1075_285690
Cites_doi 10.1089/jpm.2009.0184
10.1634/theoncologist.2015-0503
10.1016/j.jpainsymman.2015.02.029
10.3109/15360288.2014.938883
10.1089/jpm.2013.0222
10.1185/03007995.2013.840568
10.1111/j.1526-4637.2008.00461.x
10.1089/jpm.2012.0612
10.1089/jpm.2016.0316
10.1089/jpm.2015.0525
10.1089/jpm.2014.0266
10.1089/jpm.2012.0335
10.1016/j.ejpain.2008.01.013
10.1002/chir.10303
ContentType Journal Article
Copyright Elsevier Inc.
2018 Elsevier Inc.
Copyright_xml – notice: Elsevier Inc.
– notice: 2018 Elsevier Inc.
DBID AAYXX
CITATION
DOI 10.1016/j.hoc.2018.01.004
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-1977
EndPage 415
ExternalDocumentID 10_1016_j_hoc_2018_01_004
S0889858818300145
1_s2_0_S0889858818300145
GroupedDBID ---
.1-
.FO
.GJ
0R~
1P~
34G
39C
4.4
457
4CK
53G
5GY
5RE
AAEDT
AAEDW
AALRI
AAQQT
AAQXK
AAWTL
AAXUO
ABCQX
ABFRF
ABJNI
ABMAC
ABOCM
ABPPZ
ABQZK
ADBBV
ADMUD
AEFWE
AEVXI
AFCTW
AFFNX
AFRHN
AFTJW
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AXIYT
AZFZN
B08
COIAO
CS3
DAHGL
EBS
EJD
EX3
F5P
FDB
FEDTE
FGOYB
HVGLF
HZ~
IH2
J5H
N4W
O9-
OC~
OO-
R2-
RIG
SEL
SES
TWZ
UDS
UNMZH
WH7
WOW
Z5R
ZGI
ZXP
AAIAV
AAYXX
CITATION
ID FETCH-LOGICAL-c1974-ed0b62bc924cc4d778cc8d49ed5189757a0e89ffc45046197f37cfe345d3a05f3
ISSN 0889-8588
IngestDate Fri Aug 23 02:33:13 EDT 2024
Fri Feb 23 02:24:35 EST 2024
Tue Oct 15 22:56:15 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Opioid
Cancer pain
Methadone
Analgesics
Pain management
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1974-ed0b62bc924cc4d778cc8d49ed5189757a0e89ffc45046197f37cfe345d3a05f3
PageCount 11
ParticipantIDs crossref_primary_10_1016_j_hoc_2018_01_004
elsevier_sciencedirect_doi_10_1016_j_hoc_2018_01_004
elsevier_clinicalkeyesjournals_1_s2_0_S0889858818300145
PublicationCentury 2000
PublicationDate June 2018
PublicationDateYYYYMMDD 2018-06-01
PublicationDate_xml – month: 06
  year: 2018
  text: June 2018
PublicationDecade 2010
PublicationTitle Hematology/oncology clinics of North America
PublicationYear 2018
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Accessed October 10, 2017.
Wallace, Ridley, Bryson (bib16) 2013; 16
Salpeter, Buckley, Buckley (bib18) 2015; 18
Accessed October 8, 2017.
Porta-Sales, Garzon-Rodriguez, Villavicencio-Chavez (bib7) 2016; 21
Methadone. Micromedex solutions. Ann Arbor (MI): Truven Health Analytics, Inc. Available at
Nova Scotia Health Authority. Using methadone for chronic pain: patient & family guide. 2017. Available at
Salpeter, Buckley, Bruera (bib17) 2013; 16
McPherson (bib13) 2016; 17
Weschules, Bain (bib15) 2008; 9
Leavitt (bib25) 2008
Rhondali, Tremellat, Ledoux (bib4) 2013; 16
Neto, Garcia, Garcia (bib3) 2015; 16
U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. 2016. Available at
Bart, Wyman, Wang (bib10) 2017; 11
Reddy, Schuler, de la Cruz (bib8) 2017; 20
Mercadante, Porzio, Ferrera (bib6) 2008; 12
Good, Afsharimani, Movva (bib1) 2014; 28
Credible Meds. Available at
Gerber, Rhodes, Gal (bib5) 2004; 16
Trinkley, Page, Lien (bib11) 2013; 29
Chou, Cruciani, Fiellin (bib9) 2014; 15
McLean, Twomey (bib14) 2015; 50
Accessed October 15, 2017.
VA National Pain Management Program. Available at
Reddy, Hui, Osta (bib12) 2010; 13
Centers for Disease Control and Prevention (bib2) 2012; 61
Courtemanche, Dao, Gagne (bib19) 2016; 19
Reddy (10.1016/j.hoc.2018.01.004_bib8) 2017; 20
McLean (10.1016/j.hoc.2018.01.004_bib14) 2015; 50
Wallace (10.1016/j.hoc.2018.01.004_bib16) 2013; 16
Neto (10.1016/j.hoc.2018.01.004_bib3) 2015; 16
Salpeter (10.1016/j.hoc.2018.01.004_bib18) 2015; 18
Courtemanche (10.1016/j.hoc.2018.01.004_bib19) 2016; 19
Gerber (10.1016/j.hoc.2018.01.004_bib5) 2004; 16
Salpeter (10.1016/j.hoc.2018.01.004_bib17) 2013; 16
Reddy (10.1016/j.hoc.2018.01.004_bib12) 2010; 13
Leavitt (10.1016/j.hoc.2018.01.004_bib25) 2008
Mercadante (10.1016/j.hoc.2018.01.004_bib6) 2008; 12
Trinkley (10.1016/j.hoc.2018.01.004_bib11) 2013; 29
Centers for Disease Control and Prevention (10.1016/j.hoc.2018.01.004_bib2) 2012; 61
Good (10.1016/j.hoc.2018.01.004_bib1) 2014; 28
10.1016/j.hoc.2018.01.004_bib24
10.1016/j.hoc.2018.01.004_bib21
10.1016/j.hoc.2018.01.004_bib20
Porta-Sales (10.1016/j.hoc.2018.01.004_bib7) 2016; 21
Weschules (10.1016/j.hoc.2018.01.004_bib15) 2008; 9
10.1016/j.hoc.2018.01.004_bib23
10.1016/j.hoc.2018.01.004_bib22
Rhondali (10.1016/j.hoc.2018.01.004_bib4) 2013; 16
Chou (10.1016/j.hoc.2018.01.004_bib9) 2014; 15
McPherson (10.1016/j.hoc.2018.01.004_bib13) 2016; 17
Bart (10.1016/j.hoc.2018.01.004_bib10) 2017; 11
References_xml – volume: 16
  start-page: 305
  year: 2013
  end-page: 309
  ident: bib16
  article-title: Addition of methadone to another opioid in the management of moderate to severe cancer pain: a case series
  publication-title: J Palliat Med
  contributor:
    fullname: Bryson
– volume: 12
  start-page: 1040
  year: 2008
  end-page: 1046
  ident: bib6
  article-title: Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management
  publication-title: Eur J Pain
  contributor:
    fullname: Ferrera
– volume: 19
  start-page: 1
  year: 2016
  end-page: 7
  ident: bib19
  article-title: Methadone as a coanalgesic for palliative care cancer patients
  publication-title: J Palliat Med
  contributor:
    fullname: Gagne
– volume: 17
  start-page: 8
  year: 2016
  end-page: 9
  ident: bib13
  article-title: Methadone safety guidelines for hospice and palliative care
  publication-title: AAHPM Quarterly
  contributor:
    fullname: McPherson
– volume: 16
  start-page: 60
  year: 2015
  end-page: 66
  ident: bib3
  article-title: Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication
  publication-title: Rev Dor. São Paulo
  contributor:
    fullname: Garcia
– volume: 50
  start-page: 248
  year: 2015
  end-page: 259
  ident: bib14
  article-title: Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence
  publication-title: J Pain Symptom Manage
  contributor:
    fullname: Twomey
– volume: 20
  start-page: 656
  year: 2017
  end-page: 661
  ident: bib8
  article-title: Overall survival among cancer patients undergoing opioid rotation to methadone compared to other opioids
  publication-title: J Palliat Med
  contributor:
    fullname: de la Cruz
– volume: 15
  start-page: 321
  year: 2014
  end-page: 337
  ident: bib9
  article-title: Methadone safety: a clinical practice guideline from the American Pain Society and College of Problems on Drug Dependence, in collaboration with the Heart Rhythm Society
  publication-title: J Pain
  contributor:
    fullname: Fiellin
– volume: 18
  start-page: 114
  year: 2015
  end-page: 119
  ident: bib18
  article-title: The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report
  publication-title: J Palliat Med
  contributor:
    fullname: Buckley
– volume: 28
  start-page: 197
  year: 2014
  end-page: 205
  ident: bib1
  article-title: Therapeutic challenges in cancer pain management: a systematic review of methadone
  publication-title: J Pain Palliat Care Pharmacother
  contributor:
    fullname: Movva
– year: 2008
  ident: bib25
  article-title: Methadone safety handout for patients
  contributor:
    fullname: Leavitt
– volume: 21
  start-page: 981
  year: 2016
  end-page: 987
  ident: bib7
  article-title: Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study
  publication-title: Oncologist
  contributor:
    fullname: Villavicencio-Chavez
– volume: 16
  start-page: 1
  year: 2013
  end-page: 7
  ident: bib17
  article-title: The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia
  publication-title: J Palliat Med
  contributor:
    fullname: Bruera
– volume: 61
  start-page: 493
  year: 2012
  end-page: 497
  ident: bib2
  article-title: Vital signs: risk for overdose from methadone used for pain relief – United States, 1999-2010
  publication-title: MMWR Morb Mortal Wkly Rep
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 16
  start-page: 36
  year: 2004
  end-page: 44
  ident: bib5
  article-title: Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
  publication-title: Chirality
  contributor:
    fullname: Gal
– volume: 29
  start-page: 1719
  year: 2013
  end-page: 1726
  ident: bib11
  article-title: QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
  publication-title: Curr Med Res Opin
  contributor:
    fullname: Lien
– volume: 16
  start-page: 1382
  year: 2013
  end-page: 1387
  ident: bib4
  article-title: Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study
  publication-title: J Palliat Med
  contributor:
    fullname: Ledoux
– volume: 9
  start-page: 595
  year: 2008
  end-page: 612
  ident: bib15
  article-title: A systematic review of opioid conversion ratios used with methadone for the treatment of pain
  publication-title: Pain Med
  contributor:
    fullname: Bain
– volume: 11
  start-page: 489
  year: 2017
  end-page: 493
  ident: bib10
  article-title: Methadone and the QTc interval: paucity of clinically significant factors in a retrospective cohort
  publication-title: J Addict Med
  contributor:
    fullname: Wang
– volume: 13
  start-page: 33
  year: 2010
  end-page: 38
  ident: bib12
  article-title: The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study
  publication-title: J Palliat Med
  contributor:
    fullname: Osta
– volume: 13
  start-page: 33
  issue: 1
  year: 2010
  ident: 10.1016/j.hoc.2018.01.004_bib12
  article-title: The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2009.0184
  contributor:
    fullname: Reddy
– volume: 21
  start-page: 981
  year: 2016
  ident: 10.1016/j.hoc.2018.01.004_bib7
  article-title: Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: a prospective open-label study
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2015-0503
  contributor:
    fullname: Porta-Sales
– ident: 10.1016/j.hoc.2018.01.004_bib21
– volume: 50
  start-page: 248
  issue: 2
  year: 2015
  ident: 10.1016/j.hoc.2018.01.004_bib14
  article-title: Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence
  publication-title: J Pain Symptom Manage
  doi: 10.1016/j.jpainsymman.2015.02.029
  contributor:
    fullname: McLean
– ident: 10.1016/j.hoc.2018.01.004_bib23
– volume: 28
  start-page: 197
  year: 2014
  ident: 10.1016/j.hoc.2018.01.004_bib1
  article-title: Therapeutic challenges in cancer pain management: a systematic review of methadone
  publication-title: J Pain Palliat Care Pharmacother
  doi: 10.3109/15360288.2014.938883
  contributor:
    fullname: Good
– volume: 16
  start-page: 1382
  issue: 11
  year: 2013
  ident: 10.1016/j.hoc.2018.01.004_bib4
  article-title: Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2013.0222
  contributor:
    fullname: Rhondali
– volume: 16
  start-page: 60
  issue: 1
  year: 2015
  ident: 10.1016/j.hoc.2018.01.004_bib3
  article-title: Revisiting methadone: pharmacokinetics, pharmacodynamics and clinical indication
  publication-title: Rev Dor. São Paulo
  contributor:
    fullname: Neto
– volume: 29
  start-page: 1719
  issue: 12
  year: 2013
  ident: 10.1016/j.hoc.2018.01.004_bib11
  article-title: QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007995.2013.840568
  contributor:
    fullname: Trinkley
– volume: 9
  start-page: 595
  issue: 5
  year: 2008
  ident: 10.1016/j.hoc.2018.01.004_bib15
  article-title: A systematic review of opioid conversion ratios used with methadone for the treatment of pain
  publication-title: Pain Med
  doi: 10.1111/j.1526-4637.2008.00461.x
  contributor:
    fullname: Weschules
– volume: 16
  start-page: 1
  issue: 6
  year: 2013
  ident: 10.1016/j.hoc.2018.01.004_bib17
  article-title: The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2012.0612
  contributor:
    fullname: Salpeter
– volume: 17
  start-page: 8
  issue: 2
  year: 2016
  ident: 10.1016/j.hoc.2018.01.004_bib13
  article-title: Methadone safety guidelines for hospice and palliative care
  publication-title: AAHPM Quarterly
  contributor:
    fullname: McPherson
– ident: 10.1016/j.hoc.2018.01.004_bib24
– volume: 20
  start-page: 656
  year: 2017
  ident: 10.1016/j.hoc.2018.01.004_bib8
  article-title: Overall survival among cancer patients undergoing opioid rotation to methadone compared to other opioids
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2016.0316
  contributor:
    fullname: Reddy
– ident: 10.1016/j.hoc.2018.01.004_bib20
– volume: 11
  start-page: 489
  issue: 6
  year: 2017
  ident: 10.1016/j.hoc.2018.01.004_bib10
  article-title: Methadone and the QTc interval: paucity of clinically significant factors in a retrospective cohort
  publication-title: J Addict Med
  contributor:
    fullname: Bart
– volume: 19
  start-page: 1
  issue: 9
  year: 2016
  ident: 10.1016/j.hoc.2018.01.004_bib19
  article-title: Methadone as a coanalgesic for palliative care cancer patients
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2015.0525
  contributor:
    fullname: Courtemanche
– ident: 10.1016/j.hoc.2018.01.004_bib22
– volume: 61
  start-page: 493
  year: 2012
  ident: 10.1016/j.hoc.2018.01.004_bib2
  article-title: Vital signs: risk for overdose from methadone used for pain relief – United States, 1999-2010
  publication-title: MMWR Morb Mortal Wkly Rep
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 18
  start-page: 114
  issue: 2
  year: 2015
  ident: 10.1016/j.hoc.2018.01.004_bib18
  article-title: The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2014.0266
  contributor:
    fullname: Salpeter
– year: 2008
  ident: 10.1016/j.hoc.2018.01.004_bib25
  contributor:
    fullname: Leavitt
– volume: 16
  start-page: 305
  issue: 3
  year: 2013
  ident: 10.1016/j.hoc.2018.01.004_bib16
  article-title: Addition of methadone to another opioid in the management of moderate to severe cancer pain: a case series
  publication-title: J Palliat Med
  doi: 10.1089/jpm.2012.0335
  contributor:
    fullname: Wallace
– volume: 12
  start-page: 1040
  year: 2008
  ident: 10.1016/j.hoc.2018.01.004_bib6
  article-title: Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management
  publication-title: Eur J Pain
  doi: 10.1016/j.ejpain.2008.01.013
  contributor:
    fullname: Mercadante
– volume: 15
  start-page: 321
  year: 2014
  ident: 10.1016/j.hoc.2018.01.004_bib9
  article-title: Methadone safety: a clinical practice guideline from the American Pain Society and College of Problems on Drug Dependence, in collaboration with the Heart Rhythm Society
  publication-title: J Pain
  contributor:
    fullname: Chou
– volume: 16
  start-page: 36
  issue: 16
  year: 2004
  ident: 10.1016/j.hoc.2018.01.004_bib5
  article-title: Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
  publication-title: Chirality
  doi: 10.1002/chir.10303
  contributor:
    fullname: Gerber
SSID ssj0015084
Score 2.2321973
SecondaryResourceType review_article
Snippet Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an N-methyl-...
Methadone is a valuable opioid in the management of patients who have cancer with pain. Methadone is a mu-, kappa-, and delta-opioid agonist, and an...
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 405
SubjectTerms Analgesics
Cancer pain
Hematology, Oncology, and Palliative Medicine
Methadone
Opioid
Pain management
Title Methadone
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0889858818300145
https://dx.doi.org/10.1016/j.hoc.2018.01.004
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LaxsxEBZOCm0voU_qPEoOOdXIaHclS3tM1k4NicOSpFB6EbuSFjcHu2Sdg_99RtI-vHlAW8hFGLF6zI48-81oHggdMaZDwwOGwziPMDXxCOcCGmbVj1FuCM-c6eKKX_wU4wmd9Hp1MZ2270U5DX3Aaxs5-w_cbiaFDvgNPIcWuA7tX_F9ZlbzTC8XHRefqc3MWsWlnC4Xyide8lGRzpejc33T2urSuQPkVVDPenC-9nA3tQmvx6772LVj51R5kqTOEzBJ2_iGpYWfq9-uwvfgcg3iJBl2p6hHnSTf0yeXroJwbrPB-YOhs3S6abYIROte1Ui3GAvma_rVorg1dbaaupOrlLCNTzT1EaCPpL83RNwM50ubnDIQLiGrr27czbQ9Sc4CXIZDgq_sPuw2QLRZdZF1H_Z6kixDSeSjR7fQqxDEm63Y8ItdNndXAHmp1108gfVduvMqfLC1p9HQBsK5fod2KtXk8NifqfeoZxYf0OtZ5XzxEb1pjtYn9ON0cp1McVVJA6sAFEZsNMlHYa5A2VaKas6FUkLT2GgWiJgznhEj4qJQlNkE_DEvIq4KE1Gmo4ywIvqMthcw_Rd0CNQHOdFhbDIL9q3CbK1iGoCQAlU67KNvNUXyj0-YImtPwhsJ5EtLviSBBPL7iNc0yzoSGL5dpqz-UKV87t33EW1GVljRY0AJh-H5BXf_e8E99LY9xvtoe3V7Zw7QVqnvvjr23wNtrXun
link.rule.ids 315,782,786,27934,27935
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Methadone&rft.jtitle=Hematology%2Foncology+clinics+of+North+America&rft.au=McPherson%2C+Mary+Lynn%2C+PharmD%2C+MA%2C+MDE%2C+BCPS%2C+CPE&rft.au=Costantino%2C+Ryan+C.%2C+PharmD%2C+BCPS%2C+BCGP&rft.au=McPherson%2C+Alexandra+L.%2C+PharmD%2C+MPH&rft.date=2018-06-01&rft.issn=0889-8588&rft.volume=32&rft.issue=3&rft.spage=405&rft.epage=415&rft_id=info:doi/10.1016%2Fj.hoc.2018.01.004&rft.externalDBID=ECK1-s2.0-S0889858818300145&rft.externalDocID=1_s2_0_S0889858818300145
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08898588%2FS0889858818X00033%2Fcov150h.gif